Literature DB >> 27925621

Presepsin for the detection of early-onset sepsis in preterm newborns.

Paolo Montaldo1,2, Roberto Rosso1, Alfredo Santantonio1, Giovanni Chello1, Paolo Giliberti1.   

Abstract

BACKGROUND: Early-onset sepsis (EOS) is responsible for an important fraction of neonatal morbidity and mortality all over the world. The aim of this study was to assess whether presepsin (P-SEP) can be a more accurate biomarker of EOS compared with pro-calcitonin (PCT) and C-reactive protein (CRP). STUDY
DESIGN: Consecutive preterm neonates (<34 wk gestational age, admitted to Neonatal Intensive Care Unit by 6 h of age and undergoing sepsis evaluation) were recruited as part of a case-matched control study. We determined CRP, PCT and P-SEP at admission, and then at 12, 24, and 48 h of age. Neonates recruited into the study were divided into the EOS group (n = 32) and the uninfected group (n =38) according to their infection screening.
RESULTS: P-SEP values were significantly higher in the EOS group than in the uninfected group at different time intervals. The highest accuracy was achieved by P-SEP at 24 h after birth. The AUC for P-SEP was 0.97. In our sample, P-SEP achieved the best accuracy for prediction of EOS at the cut-off of 788 ng/l with 93% sensitivity and 100% specificity.
CONCLUSIONS: This study shows that P-SEP is significantly higher in preterm infants with EOS compared with uninfected infants.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27925621     DOI: 10.1038/pr.2016.217

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  25 in total

1.  C-reactive protein kinetics in newborns: application of a high-sensitivity analytic method in its determination.

Authors:  Midori Ishibashi; Yuzuru Takemura; Haku Ishida; Kiyoaki Watanabe; Tadashi Kawai
Journal:  Clin Chem       Date:  2002-07       Impact factor: 8.327

2.  Development of a point-of-care assay system for measurement of presepsin (sCD14-ST).

Authors:  Yoshikazu Okamura; Hiroyuki Yokoi
Journal:  Clin Chim Acta       Date:  2011-08-03       Impact factor: 3.786

Review 3.  Translational research and biomarkers in neonatal sepsis.

Authors:  Joris R Delanghe; Marijn M Speeckaert
Journal:  Clin Chim Acta       Date:  2015-02-04       Impact factor: 3.786

4.  A case definition for national and international neonatal bloodstream infection surveillance.

Authors:  N Modi; C J Doré; A Saraswatula; M Richards; K B Bamford; R Coello; A Holmes
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2008-05-22       Impact factor: 5.747

Review 5.  Serum procalcitonin as a diagnostic marker for neonatal sepsis: a systematic review and meta-analysis.

Authors:  Evridiki K Vouloumanou; Eleni Plessa; Drosos E Karageorgopoulos; Elpis Mantadakis; Matthew E Falagas
Journal:  Intensive Care Med       Date:  2011-03-05       Impact factor: 17.440

6.  Presepsin for the detection of late-onset sepsis in preterm newborns.

Authors:  Chiara Poggi; Tommaso Bianconi; Elena Gozzini; Marta Generoso; Carlo Dani
Journal:  Pediatrics       Date:  2014-12-15       Impact factor: 7.124

Review 7.  Soluble CD14 subtype presepsin (sCD14-ST) and lipopolysaccharide binding protein (LBP) in neonatal sepsis: new clinical and analytical perspectives for two old biomarkers.

Authors:  Michele Mussap; Antonio Noto; Marco Fravega; Vassilios Fanos
Journal:  J Matern Fetal Neonatal Med       Date:  2011-10

8.  Soluble CD14 subtype (sCD14-ST) presepsin in premature and full term critically ill newborns with sepsis and SIRS.

Authors:  Michele Mussap; Elisabetta Puxeddu; Melania Puddu; Giovanni Ottonello; Ferdinando Coghe; Paola Comite; Francesco Cibecchini; Vassilios Fanos
Journal:  Clin Chim Acta       Date:  2015-07-29       Impact factor: 3.786

9.  Serial serum C-reactive protein levels in the diagnosis of neonatal infection.

Authors:  W E Benitz; M Y Han; A Madan; P Ramachandra
Journal:  Pediatrics       Date:  1998-10       Impact factor: 7.124

10.  CD14 is an acute-phase protein.

Authors:  Sylvette Bas; Benoit R Gauthier; Ursula Spenato; Sybille Stingelin; Cem Gabay
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

View more
  11 in total

1.  The Role of Presepsin Obtained from Tracheal Aspirates in the Diagnosis of Early Onset Pneumonia in Intubated Newborns.

Authors:  Dragana Savić; Aleksandra Simović; Slavica Marković; Gordana Kostić; Biljana Vuletić; Snezana Radivojević; Marina Lišanin; Zoran Igrutinović; Radisa Pavlović
Journal:  Indian J Pediatr       Date:  2018-04-14       Impact factor: 1.967

2.  Individual and combined bioscore model of presepsin, procalcitonin, and high sensitive C - reactive protein as biomarkers for early diagnosis of paediatric sepsis.

Authors:  Samuel Asamoah Sakyi; Anthony Enimil; David Kwabena Adu; Richard Dadzie Ephraim; Kwabena Owusu Danquah; Linda Fondjo; David Baidoe-Ansah; Prince Adoba; Emmanuel Toboh; Bright Oppong Afranie
Journal:  Heliyon       Date:  2020-09-14

Review 3.  The diagnostic accuracy of presepsin in neonatal sepsis: a meta-analysis.

Authors:  Ioannis Bellos; Georgia Fitrou; Vasilios Pergialiotis; Nikolaos Thomakos; Despina N Perrea; Georgios Daskalakis
Journal:  Eur J Pediatr       Date:  2018-02-23       Impact factor: 3.183

4.  The diagnostic utility of procalcitonin, interleukin-6 and interleukin-8, and hyaluronic acid in the Norwegian consensus definition for early-onset neonatal sepsis (EONS).

Authors:  Britt Nakstad
Journal:  Infect Drug Resist       Date:  2018-03-08       Impact factor: 4.003

5.  The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review.

Authors:  Lin Ruan; Guan-Yu Chen; Zhen Liu; Yun Zhao; Guang-Yu Xu; Shu-Fang Li; Chun-Ni Li; Lin-Shan Chen; Zheng Tao
Journal:  Crit Care       Date:  2018-11-21       Impact factor: 9.097

Review 6.  Approach to Neonates and Young Infants with Fever without a Source Who Are at Risk for Severe Bacterial Infection.

Authors:  Susanna Esposito; Victoria Elisa Rinaldi; Alberto Argentiero; Edoardo Farinelli; Marta Cofini; Renato D'Alonzo; Antonella Mencacci; Nicola Principi
Journal:  Mediators Inflamm       Date:  2018-11-26       Impact factor: 4.711

7.  Soluble CD14 subtype (sCD14-ST) as biomarker in neonatal early-onset sepsis and late-onset sepsis: a systematic review and meta-analysis.

Authors:  Iris van Maldeghem; Charlotte M Nusman; Douwe H Visser
Journal:  BMC Immunol       Date:  2019-06-03       Impact factor: 3.615

Review 8.  Biomarkers for Point-of-Care Diagnosis of Sepsis.

Authors:  Andrew Teggert; Harish Datta; Zulfiqur Ali
Journal:  Micromachines (Basel)       Date:  2020-03-10       Impact factor: 2.891

9.  Presepsin (Soluble CD14 Subtype) as an Early Marker of Neonatal Sepsis and Septic Shock: A Prospective Diagnostic Trial.

Authors:  Carlo Pietrasanta; Andrea Ronchi; Claudia Vener; Chiara Poggi; Claudia Ballerini; Lea Testa; Rosaria Maria Colombo; Elena Spada; Carlo Dani; Fabio Mosca; Lorenza Pugni
Journal:  Antibiotics (Basel)       Date:  2021-05-14

10.  Prediction of Postoperative Sepsis Based on Changes in Presepsin Levels of Critically Ill Patients with Acute Kidney Injury after Abdominal Surgery.

Authors:  Chang Hwan Kim; Eun Young Kim
Journal:  Diagnostics (Basel)       Date:  2021-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.